You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Artemether; lumefantrine - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for artemether; lumefantrine and what is the scope of freedom to operate?

Artemether; lumefantrine is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for artemether; lumefantrine

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Clinical Trials:	175
DailyMed Link:	artemether; lumefantrine at DailyMed

Recent Clinical Trials for artemether; lumefantrine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
The Swedish Research Council	Phase 2/Phase 3
Muhimbili University of Health and Allied Sciences	Phase 2/Phase 3
Duke University	Phase 4

See all artemether; lumefantrine clinical trials

Pharmacology for artemether; lumefantrine

Drug Class	Antimalarial

Anatomical Therapeutic Chemical (ATC) Classes for artemether; lumefantrine

P01BE	Artemisinin and derivatives, plain
P01B	ANTIMALARIALS
P01	ANTIPROTOZOALS
P	Antiparasitic products, insecticides and repellents

P01BF	Artemisinin and derivatives, combinations
P01B	ANTIMALARIALS
P01	ANTIPROTOZOALS
P	Antiparasitic products, insecticides and repellents

US Patents and Regulatory Information for artemether; lumefantrine

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	COARTEM	artemether; lumefantrine	TABLET;ORAL	022268-001	Apr 7, 2009		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for artemether; lumefantrine

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	COARTEM	artemether; lumefantrine	TABLET;ORAL	022268-001	Apr 7, 2009	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.